The purpose of this Funding Opportunity Announcement is to support studies that will evaluate HIV drug resistance and its relationship to treatment success.
Applications are sought proposing studies of genotype/phenotype correlations in diverse subtypes, the relationship between drug resistance
mutations present in minority variant viral populations and treatment outcomes, and on the reasons for the discordance between genotype and treatment success or failure.
Laboratory evaluations of samples with clinical correlates in patients on recommended regimens are encouraged.